WCLC 2018: Success of combined screening and smoking cessation pilots
Written by Karen Ramirez | 17 Oct 2018
Professor Gail Darling (WCLC co-President, Toronto, Canada) discusses the success of combined screening and smoking cessation pilot in Ontario.
WCLC 2018: Do we have a UK-wide screening programme that is ready to implement?
Written by Karen Ramirez | 17 Oct 2018
Dr Jesme Fox (Roy Castle Lung Cancer Foundation, UK) and Professor David Baldwin (Nottingham, UK) detail current UK pilots and a screening protocol that is currently going through the NHS England… read more.
WCLC 2018: NELSON – CT screening saves lives
Written by Karen Ramirez | 17 Oct 2018
A randomised, controlled screening trial for lung cancer involving almost 16,000 people in the Netherlands and Belgium found that CT screening produced a 26% reduction in lung cancer… read more.
WCLC 2018: Highlights
Written by Karen Ramirez | 17 Oct 2018
The IASLC 19th World Conference on Lung Cancer (WCLC) was full of highlights, including 3 plenary abstracts being presented in the New England Journal of Medicine and involvement from… read more.
DDW 2018: Quality of life for IBD patients
Written by Karen Ramirez | 2 Oct 2018
Inflammatory bowel disease can have a detrimental impact of health-related quality of life, and reducing the physical and psychological disease burden is an important therapeutic target. Patient-reported outcomes… read more.
DDW 2018: Predicting who will get IBD
Written by Karen Ramirez | 2 Oct 2018
To have a chance of preventing IBD clinicians need to be able to predict who is at risk, based on sensitive and selective risk factors. In a translational… read more.
DDW 2018: Choice in patient management
Written by Karen Ramirez | 2 Oct 2018
IBD specialists have more treatment options than ever before; yet the optimal use of many agents, old as well as new, remains to be defined. A plenary session… read more.
DDW 2018: Treatment of perianal fistulising disease
Written by Karen Ramirez | 2 Oct 2018
Perianal fistulas remain a debilitating complication for CD patients, with high levels of morbidity and impact on quality of life. Several abstracts and posters at DDW 2018 addressed… read more.
DDW 2018: IBD Study Updates
Written by Karen Ramirez | 2 Oct 2018
This article summarises some of the key study updates presented at DDW 2018.
ASCO 2018: Synchronous primary lung cancers
Written by Karen Ramirez | 20 Aug 2018
Professor John Lafrate (Harvard Medical School, Boston) and Professor Frank Detterbeck (Yale School of Medicine, New Haven) spoke in a session looking at some of the difficulties with diagnosis and… read more.
ASCO 2018: KEYNOTE-042 shows OS
Written by Karen Ramirez | 20 Aug 2018
First-line treatment with the PD-1 inhibitor pembrolizumab showed an overall survival benefit compared to platinum-based chemotherapy in patients with locally advanced or metastatic non-small cell lung cancer and… read more.
ASCO 2018: Choices for front-line NSCLC
Written by Karen Ramirez | 20 Aug 2018
With permutations of potential front-line treatments for non-small cell lung cancer (NSCLC) seemingly endless, one thing seems certain…
Subscribe for our mailing list
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
This website uses cookies to enhance your browsing experience, analyse site traffic, and personalise content. By clicking “Accept” you consent to the use of all cookies. You can manage your preferences or withdraw consent at any time by visiting our cookie settings.
Functional Always active
Preferences
Statistics
Marketing
If you’re a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
